Equip Your Patients for Guideline-Compliant Home Rehabilitation
The Tigo 558: A trusted HSE supplier providing the technology to help your ESD team deliver on the National Stroke Strategy.
The ESD Challenge
The Irish healthcare system is in a period of rapid transformation. The 2024 INAS report shows a 13% rise in stroke admissions against only a 2% rise in specialist beds.
The HSE’s National Stroke Strategy, backed by a €5.0 million Budget 2025 allocation and 56 new specialist posts, is the solution. This strategy is built on the rapid expansion of Early Supported Discharge (ESD) teams.
This creates a new clinical challenge: How can your team deliver the more intensive rehab mandated by the 2023 Guideline to a growing community-based caseload?
The Tigo 558: A Purpose-Built Solution for ESD
The Tigo 558 is a workhorse for neurological rehabilitation. It enables your patients to achieve the high-dosage, repetitive exercise required for motor recovery between your home visits.
Benefits for Your Service & Patients
Deliver on Intensity
The 2023 Guideline calls for more intensive therapy. The Tigo’s passive, assisted, and active modes allow patients of all abilities (including hemiplegia) to safely achieve a high volume of movement, stimulating neuroplasticity.
Enable Self-Directed Therapy
The Tigo is the ideal tool to prescribe self-directed therapy, a new focus of the 2023 Guideline. It is safe, easy to use independently, and empowers patients to take ownership of their recovery.
A Platform for Telerehabilitation
The new guideline explicitly recommends services have the infrastructure for remotely delivered therapy. The Tigo provides the measurable feedback needed to monitor patients remotely, manage your caseload more effectively, and make telerehabilitation a reality.
A Trusted, Compliant Partner
As an established HSE supplier, we understand the requirements for prescribing aids and appliances. Our flexible rental model eliminates patient risk and supports your discharge planning.